3 T反转恢复磁敏感加权成像联合增强T2加权改善脑皮质下软脑膜型多发性硬化病灶的可视化
研究开发了3 T反转恢复磁敏感加权成像联合增强T2加权(IR-SWIET)序列,并与MP2RAGE、DIR、T2*加权分段EPI及相位敏感反转恢复序列对比显示皮质及软脑膜下病灶。结果显示IR-SWIET对软脑膜下病灶的敏感度(29%±8%)高于其他3 T方法,联合MP2RAGE与FLAIR方案共识别147个软脑膜下病灶,优于对照组合的83个。
要点
- IR-SWIET对软脑膜下病灶的敏感度为29%±8%,显著高于DIR、FLAIR、T2*加权EPI及PSIR。
- 联合IR-SWIET、MP2RAGE与FLAIR可识别147个软脑膜下病灶,优于联合DIR、MP2RAGE与FLAIR的83个。
- 3 T下联合IR-SWIET与MP2RAGE方案可改善皮质病灶的可视化,可能有助于提高MS诊断特异性。
关键影像表现/征象
- IR-SWIET上皮质尤其软脑膜下病灶较其他3 T方法更明显。
- IR-SWIET识别101个真阳性软脑膜下病灶,平均每例敏感度29%±8%。
- MP2RAGE识别36个软脑膜下病灶(敏感度5%±2%),与IR-SWIET比较P=0.07。
- FLAIR识别17个(敏感度2%±1%),DIR识别28个(6%±2%),T2*加权分段EPI识别42个(11%±5%),PSIR识别13个(4%±2%),与IR-SWIET比较均P<0.05。
- 联合IR-SWIET、MP2RAGE与FLAIR识别147个软脑膜下病灶(30%±5%),联合DIR、MP2RAGE与FLAIR识别83个(16%±3%),P<0.01。
诊断标准与关键数值
- 以7 T T2*和MP2RAGE图像为金标准验证3 T图像上识别的病灶。
- IR-SWIET敏感度29%±8%,MP2RAGE 5%±2%,FLAIR 2%±1%,DIR 6%±2%,T2*加权分段EPI 11%±5%,PSIR 4%±2%。
- 联合IR-SWIET、MP2RAGE与FLAIR敏感度30%±5%,联合DIR、MP2RAGE与FLAIR敏感度16%±3%。
临床应用与阅片要点
- 3 T方案中联合IR-SWIET与MP2RAGE可改善皮质病灶的可视化,IR-SWIET可能有助于提高MS诊断特异性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Cortical demyelination is common in multiple sclerosis (MS) and can be extensive. Cortical lesions contribute to disability independently from white matter lesions and may form via a distinct mechanism. However, current magnetic resonance imaging methods at 3 T are insensitive to cortical, and especially subpial cortical, lesions. Subpial lesions are well seen on T2*-weighted imaging at 7 T, but T2*-weighted methods on 3 T scanners are limited by poor lesion-to-cortex and cerebrospinal fluid-to-lesion contrast. We aimed to develop and evaluate a cerebrospinal fluid-suppressed, T2*-weighted sequence optimized for subpial cortical lesion visualization.
MATERIALS AND METHODS: We developed a new magnetic resonance imaging sequence, inversion recovery susceptibility weighted imaging with enhanced T2 weighting (IR-SWIET; 0.8 mm × 0.8 mm in plane, 0.64 mm slice thickness with whole brain coverage, acquisition time ~5 minutes). We compared cortical lesion visualization independently on IR-SWIET (median signal from 4 acquisitions), magnetization-prepared 2 rapid acquisition gradient echoes (MP2RAGE), double inversion recovery (DIR), T2*-weighted segmented echo-planar imaging, and phase-sensitive inversion recovery images for 10 adults with MS. We also identified cortical lesions with a multicontrast reading of IR-SWIET (median of 2 acquisitions), MP2RAGE, and fluid-attenuated inversion recovery (FLAIR) images for each case. Lesions identified on 3 T images were verified on "gold standard" 7 T T2* and MP2RAGE images.
RESULTS: Cortical, and particularly subpial, lesions appeared much more conspicuous on IR-SWIET compared with other 3 T methods. A total of 101 true-positive subpial lesions were identified on IR-SWIET (average per-participant sensitivity vs 7 T, 29% ± 8%) versus 36 on MP2RAGE (5% ± 2%; comparison to IR-SWIET sensitivity, P = 0.07), 17 on FLAIR (2% ± 1%; P < 0.05), 28 on DIR (6% ± 2%; P < 0.05), 42 on T2*-weighted segmented echo-planar imaging (11% ± 5%; P < 0.05), and 13 on phase-sensitive inversion recovery (4% ± 2%; P < 0.05). When a combination of IR-SWIET, MP2RAGE, and FLAIR images was used, a total of 147 subpial lesions (30% ± 5%) were identified versus 83 (16% ± 3%, P < 0.01) on a combination of DIR, MP2RAGE, and FLAIR. More cases had at least 1 subpial lesion on IR-SWIET, and IR-SWIET improved cortical lesion subtyping accuracy and correlation with 7 T subpial lesion number.
CONCLUSIONS: Subpial lesions are better visualized on IR-SWIET compared with other 3 T methods. A 3 T protocol combining IR-SWIET with MP2RAGE, in which leukocortical lesions are well seen, improves cortical lesion visualization over existing approaches. Therefore, IR-SWIET may enable improved MS diagnostic specificity and a better understanding of the clinical implications of cortical demyelination.
引用
- Beck ES, Gai N, Filippini S, et al. Inversion Recovery Susceptibility Weighted Imaging With Enhanced T2 Weighting at 3 T Improves Visualization of Subpial Cortical Multiple Sclerosis Lesions. Invest Radiol. 2020. PMID: 32604385. doi:10.1097/RLI.0000000000000698
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。